GLP-1 Check — India's GLP-1 Information & Self-Assessment Tool
Updated daily

GLP-1 & Semaglutide News (India)

India-first daily coverage of GLP-1 therapy — DCGI approvals, Indian generic launches (Sundae, Noveltreat, Obeda, Semabest…), price cuts, Mounjaro / tirzepatide updates, and trial readouts (STEP, SUSTAIN, SURMOUNT, SELECT).

200 articles

In India

17 articles
IndiaRediff·2 days ago

Weight Loss Drugs: Doctors Warn Against Panic

Weight Loss Drugs: Doctors Warn Against Panic Rediff

IndiaBusiness Standard·3 days ago

Indian drugmakers take generic semaglutide battle to overseas markets

Indian drugmakers take generic semaglutide battle to overseas markets Business Standard

IndiaThe Hawk·3 days ago

Florence Pugh slams body shaming, denies Ozempic use says ‘never done any face surgery’

Florence Pugh slams body shaming, denies Ozempic use says ‘never done any face surgery’ The Hawk

IndiaIndia TV News·4 days ago

Florence Pugh slams claims of Ozempic use and cosmetic surgery, says online scrutiny of her body is disturbing

Florence Pugh slams claims of Ozempic use and cosmetic surgery, says online scrutiny of her body is disturbing India TV News

Research & Trials

42 articles
ResearchBioengineer.org·1 day ago

Semaglutide May Improve Disordered Eating Symptoms in Adults Treating Obesity

Semaglutide May Improve Disordered Eating Symptoms in Adults Treating Obesity Bioengineer.org

ResearchFirstpost·1 day ago

Cheaper semaglutide is in India, but experts want more proof of long-term heart and kidney benefits

Cheaper semaglutide is in India, but experts want more proof of long-term heart and kidney benefits Firstpost

ResearchAssociation of Health Care Journalists·1 day ago

Get the skinny on GLP-1 safety

Get the skinny on GLP-1 safety Association of Health Care Journalists

ResearchU.S. News & World Report·2 days ago

On a GLP-1 This Holiday? How to Enjoy the Big Feast Without Side Effects - U.S. News & World Report

On a GLP-1 This Holiday? How to Enjoy the Big Feast Without Side Effects U.S. News & World Report

Regulation

128 articles
RegulationThe Hype Magazine·1 day ago

FDA Mandates New Warning Labels on Ozempic and Wegovy Over Rare Vision Loss Risk

FDA Mandates New Warning Labels on Ozempic and Wegovy Over Rare Vision Loss Risk The Hype Magazine

RegulationJD Supra·2 days ago

FDA's NAION Warning Affects Who May Qualify for a GLP-1 Vision Loss Claim

FDA's NAION Warning Affects Who May Qualify for a GLP-1 Vision Loss Claim JD Supra

RegulationFoodNavigator.com·2 days ago

GLP-1 vision warning: Could demand be affected?

GLP-1 vision warning: Could demand be affected? FoodNavigator.com

RegulationLondon Insider·2 days ago

FDA Issues NAION Warning Across GLP-1 Drug Class As Lilly Expands Zepbound Access Through Hims & Hers

FDA Issues NAION Warning Across GLP-1 Drug Class As Lilly Expands Zepbound Access Through Hims & Hers London Insider

Global

13 articles
Globalcwibc.co.id·3 days ago

Health Canada Approves Eli Lilly Foundayo Weight Loss Pill

Health Canada Approves Eli Lilly Foundayo Weight Loss Pill cwibc.co.id

GlobalSSBCrack·3 days ago

Health Canada approves Eli Lilly’s daily Foundayo pill for weight loss and Type 2 diabetes

Health Canada approves Eli Lilly’s daily Foundayo pill for weight loss and Type 2 diabetes SSBCrack

Global24/7 Wall St.·3 days ago

$1,000 Invested in Eli Lilly 10 Years Ago Would Be Worth a Fortune Today

$1,000 Invested in Eli Lilly 10 Years Ago Would Be Worth a Fortune Today 24/7 Wall St.

GlobalCastanet·4 days ago

Health Canada approves Eli Lilly's GLP-1 pill for weight loss

Health Canada approves Eli Lilly's GLP-1 pill for weight loss Castanet

News articles are aggregated from third-party RSS feeds. GLP-1 Check does not endorse or verify individual articles. Content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any treatment.